AQ Biotech Ltd

AQ Biotech Ltd is a pioneering force in biotechnology research, specializing in the innovative application of bacteriophages as biosensors. Our core focus lies in biomarker discovery, employing a unique approach to detect early indicators of chronic diseases, including prostate, lung, metastatic cancer, and Parkinson’s disease. AQ Biotech Ltd is strategically positioned to serve key markets in Finland (EU) and China, addressing the critical need for early detection and screening solutions with a profound impact on individual health and societal well-being.

AQ Biotech Ltd’s proprietary biosensors represent a significant advancement in diagnostic technology, allowing for the identification of novel and complementary biomarkers that traditional methods often miss. This commitment to innovation is driven by a dedicated team focused on developing accessible and impactful healthcare solutions. Our headquarters are located at Itäinen pitkäkatu 4B 4floor, Turku, 20520, FI, and we are poised for continued expansion and growth within the global biotechnology landscape.

AQ Biotech Ltd is dedicated to improving healthcare outcomes through cutting-edge research and development. We envision a future where diseases are detected earlier, leading to more effective treatment and improved quality of life for individuals worldwide. The team at AQ Biotech Ltd is passionately committed to advancing the field of biomarker discovery and delivering value to patients and partners alike. We invite you to collaborate with us in creating a customized and exclusive company showcase and product listing on our platform, highlighting the transformative potential of AQ Biotech Ltd.